The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Enrolling by invitationOBSERVATIONAL
Enrollment

1,976

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

January 31, 2027

Study Completion Date

August 30, 2027

Conditions
DiabetesAlzheimer DiseaseDementia, VascularDementiaPreDiabetes
Trial Locations (27)

10032

Columbia University Medical Center, New York

Columbia University, New York

10461

Albert Einstein College of Medicine, The Bronx

15213

University of Pittsburgh, Pittsburgh

19107

Thomas Jefferson University, Philadelphia

20003

Medstar Health Research Institute, Washington D.C.

20852

Biostatistics Center, George Washington University, Rockville

21093

Johns Hopkins University, Lutherville

33136

University of Miami, Miami

38103

University of Tennessee, Memphis

46202

Indiana University, Indianapolis

60611

Northwestern University, Chicago

60637

University of Chicago, Chicago

63110

Washington University, St Louis

70808

Pennington Biomedical Center, Baton Rouge

78229

University of Texas Health Science Center San Antonio, San Antonio

80045

University of Colorado, Aurora

85016

SW American Indian Center - Phoenix, Phoenix

87131

University of New Mexico, Albuquerque

87327

SW American Indian Center - Zuni, Zuni

87420

SW American Indian Center - Shiprock, Shiprock

91801

University of California Los Angeles, Alhambra

92128

University of California San Diego, San Diego

96813

University of Hawaii, Honolulu

98108

University of Washington, VA Puget Sound Health Care System, Seattle

02114

Massachusetts General Hospital, Boston

02215

Joslin Diabetes Center, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Marinella Temprosa

OTHER

NCT05704309 - The Diabetes Prevention Program Outcomes Study AD/ADRD Project | Biotech Hunter | Biotech Hunter